Filing Signals

Source: SEC EDGAR Compiled 2026-09-14 08:28 UTC All 21 checks passing

← All events

REGENEREX PHARMA, INC.

CIK 1357878 ·Pharmaceutical Preparations · All EDGAR filings ↗

Progression

  1. Late filing NT 10-K
  2. Auditor change 8-K +158d
Refine
Form
An amendment is grouped with the report it amends; every 12b-25 notice is one group

Auditor change high SEC item code

REGENEREX PHARMA, INC.'s auditor resigned

The auditor resigned. No disagreements disclosed.

Evidence
Direction
resigned
Direction label
The auditor resigned
Disagreements disclosed
No
Item code
4.01
Item title
Changes in Registrant's Certifying Accountant
Severity
high
Source
SEC 8-K item code
Why
The company's independent registered accounting firm changed.

Source filing ↗

Late filing high Filing comparison

REGENEREX PHARMA, INC. told the SEC it could not file its annual report on time

Regenerex Pharma Inc. is unable to file its Form 10-K within the prescribed time period without unreasonable effort or expense, as additional time is required to complete its financial statements, related disclosures, and audit procedures. This delay is primarily due to an ongoing internal review of certain matters raised by a company executive, as well as the need for continued coordination with the Company’s external auditors and consultation with legal counsel to ensure the accuracy and completeness of the filing. The internal review was initiated by the independent members of the Board of Directors and remains ongoing. The Company’s auditors have advised that they are unable to complete…
Evidence
Days past due date
-1
Routine
No
Severity
high
Source
Form 12b-25 (notification of late filing)
Stated reason
Regenerex Pharma Inc. is unable to file its Form 10-K within the prescribed time period without unreasonable effort or expense, as additional time is required to complete its financial statements, related disclosures, and audit procedures. This delay is primarily due to an ongoing internal review of certain matters raised by a company executive, as well as the need for continued coordination with the Company’s external auditors and consultation with legal counsel to ensure the accuracy and completeness of the filing. The internal review was initiated by the independent members of the Board of Directors and remains ongoing. The Company’s auditors have advised that they are unable to complete…
Why
The company told the SEC it could not file a periodic report on time, using Form 12b-25.

Source filing ↗